Insider · CIK 0001590157
Andrew R Robbins
Files at COGT (Cogent Biosciences, Inc.). First filing -, latest -.
Andrew R Robbins files SEC Form 4 as CEO, president and director at COGT (Cogent Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Andrew R Robbins has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 19, 2026 | COGT Cogent Biosciences, Inc. | GGift Common Stock | -160,000 | $0.00 | $0 | 497,503 | May 21, 2026 |
| May 19, 2026 | COGT Cogent Biosciences, Inc. | GGift Common Stockindirect: By trust | +160,000 | $0.00 | $0 | 160,000 | May 21, 2026 |
| Dec 17, 2025 | COGT Cogent Biosciences, Inc. | AGrant or award Common Stock | +185,000 | $0.00 | $0 | 185,000 | Dec 19, 2025 |
| Dec 17, 2025 | COGT Cogent Biosciences, Inc. | AGrant or award Common Stock | +840,000 | $0.00 | $0 | 1,025,000 | Dec 19, 2025 |
| Dec 17, 2025 | COGT Cogent Biosciences, Inc. | FTax withholding Common Stock | -367,497 | $39.45 | $14M | 657,503 | Dec 19, 2025 |
| Dec 17, 2025 | COGT Cogent Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +245,000 | $0.00 | $0 | 245,000 | Dec 19, 2025 |
| Jan 23, 2025 | COGT Cogent Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +915,000 | $0.00 | $0 | 915,000 | Jan 27, 2025 |
Questions about Andrew R Robbins
Answered from the filings on this page, as of the latest one.
Is Andrew R Robbins buying or selling?
Andrew R Robbins has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Andrew R Robbins's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Andrew R Robbins has 0.
Where does Andrew R Robbins file Form 4?
Andrew R Robbins has filed Form 4 at COGT (Cogent Biosciences, Inc.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.